East African botanical compounds for chronic inflammatory skin disease therapies
Discovery and development of novel anti-inflammatory and immunomodulatory compounds from East African medicinal plants for long-acting therapies targeting chronic inflammatory skin diseases. The program combines ethnobotanical knowledge with modern isolation, mechanistic, and clinical validation methods.
Overview
This research program harnesses the rich medicinal plant heritage of East Africa to discover and develop novel therapies for chronic inflammatory skin diseases. The initiative addresses significant limitations in current treatments by exploring plant-derived bioactive compounds with anti-inflammatory and immunomodulatory properties. By combining traditional ethnobotanical knowledge with modern pharmaceutical science, the program aims to deliver long-acting, multi-pathway therapies for debilitating skin conditions.
The approach targets compounds capable of modulating multiple disease pathways, offering potential advantages over single-target therapies. The research spans the full development pipeline from plant identification through clinical trials, creating a comprehensive pathway from biodiversity to bedside treatment.
Technical specifications
Research approach:
- Identification and isolation of bioactive compounds from selected East African medicinal plants with documented traditional dermatological use
- In vitro evaluation of anti-inflammatory and immunomodulatory effects using relevant cell lines
- Chemical structure determination using chromatographic and spectroscopic techniques
- Efficacy and safety assessment in animal models of chronic inflammatory skin diseases
- Molecular mechanism studies to understand therapeutic action
- Formulation of bioactive compounds into appropriate delivery systems
- Pharmacokinetic and pharmacodynamic characterization including absorption, distribution, metabolism, and excretion properties
- Design and execution of Phase I, II, and III clinical trials
Key capabilities:
- Access to authentic plant material through collaboration with local experts
- Bioactive compound isolation and purification infrastructure
- Preclinical testing capabilities for dermatological indications
- Clinical trial design expertise
Technology readiness level
The program is at an early research stage. Traditional use and ethnobotanical studies have provided initial leads, and preclinical studies in animal models have demonstrated promising anti-inflammatory effects and improved skin lesions for some compounds. The comprehensive seven-phase research plan outlines systematic progression from compound identification through clinical validation. Further research, including clinical trials, is needed to fully validate the therapeutic potential and develop safe and effective treatments for chronic inflammatory skin conditions.
About Egerton University
Egerton University is a public research university with an applied, agriculture-centered character, headquartered in Njoro and operating additional programs in Nakuru City. Its industry interface combines large on-campus training and commercial farms at Tatton and Ngongongeri with an Agro-Science Park that offers incubation, demonstration acreage, and pilot-scale processing while brokering partnerships with agribusiness. A dedicated Directorate of Research & Extension coordinates outreach, field trials, and consultancy, creating direct pathways for companies to test and scale solutions with regional producers. Research is supported by competitive national and international funding, including Kenya’s National Research Fund and the World Bank’s Africa Centres of Excellence program. Commercialization is enabled by a technology transfer office and intellectual property support that guide licensing and startup formation.
delivered to your inbox.